ADA Scientific Sessions 2026 Abstract

Glucagon-like Peptide 1 Receptor Agonist Use in Youth with Type 1 Diabetes Mellitus at an Academic Pediatric Medical Center

By Erika Choi, Andrew Jergel, Kristina Cossen, Daniel S. Hsia

Study in peopleInterventions

The paper

Erika Choi, Andrew Jergel, Kristina Cossen, Daniel S. Hsia

Atlanta

ADA Scientific Sessions 2026 Abstract, 5 Jun 2026

Presented at ADA Scientific Sessions 2026, late-breaking 2949-LB

doi.org/10.2337/db26-2949-lb

Diabetes & Vascular Disease Research4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Diabetes, Obesity & Metabolism4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Diabetes, Obesity & Metabolism8 Oct 2026
Diabetes drug class linked to slightly less frailty progression
Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial